Damien Zanker

Geçmiş katılımlar

• 11th CAR-TCR Summit 2026

  15–17 Sept 2026Boston, United States of America

  • KonuşmacıBuilding Quality into iPSCs Early to Minimise Testing, Improve Reproducibility & Accelerate Commercialisation
• 6th iPSC Drug Development Summit

  9–10 Sept 2026Boston, United States of America

  • KonuşmacıManufacturing iPSC Therapies at Scale, Advancing Off-the-Shelf CAR-NK Production

Şu etkinlikteki diğer konuşmacılar: 11th CAR-TCR Summit 2026

• James Adams

  Chief Technical Officer, Tr1x therapeutics

• Stephan Krause

  Executive Director, Analytical Strategy, Cell Therapy Global Quality, Bristol Myers Squibb

• Michael Mingueneau

  Vice President, Immunology, Sail Biomedicines

• Nikhil Mutyal

  Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

• Luke Pase

  Chief Technology Officer, Anocca AB

• Daniel Shelly

  Chief Business Development Officer, PolTREG

Etkinlik sayfasında 83 konuşmacının tümünü gör

Şu etkinlikteki diğer konuşmacılar: 6th iPSC Drug Development Summit

• Yasunori Aizawa

  Chief Scientific Officer, Logomix, Inc.

• Seongho Bae

  Head of Research & Development, Karis Bio

• Stefan Braam

  President & Chief Technology Officer, Cellistic

• Matthew Buckley

  Chief Executive Officer & Co-Founder, Theseus Therapies

• Frederic Cedrone

  Vice President, Corporate Innovation, Catalent, Inc.

• JC Chi

  Director, BeOne Medicines

Etkinlik sayfasında 32 konuşmacının tümünü gör